These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11980279)

  • 21. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
    Brightling CE; Monteiro W; Ward R; Parker D; Morgan MD; Wardlaw AJ; Pavord ID
    Lancet; 2000 Oct; 356(9240):1480-5. PubMed ID: 11081531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sputum ECP levels correlate with parameters of airflow obstruction.
    Virchow JC; Hölscher U; Virchow C
    Am Rev Respir Dis; 1992 Sep; 146(3):604-6. PubMed ID: 1519835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous and induced sputum to measure indices of airway inflammation in asthma.
    Pizzichini MM; Popov TA; Efthimiadis A; Hussack P; Evans S; Pizzichini E; Dolovich J; Hargreave FE
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):866-9. PubMed ID: 8887576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
    Maestrelli P; Saetta M; Mapp CE; Fabbri LM
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of induced sputum in the diagnostics of selected chronic inflammatory airway diseases].
    Sozańska E; Barczyk A; Biedroń-Machura M; Pierzchała W
    Pneumonol Alergol Pol; 2009; 77(4):349-56. PubMed ID: 19722139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced sputum cell count and cytokine profile in atopic and non-atopic children with asthma.
    Vizmanos-Lamotte G; Moreno-Galdó A; Muñoz X; Gómez-Ollés S; Gartner S; Cruz MJ
    Pediatr Pulmonol; 2013 Nov; 48(11):1062-9. PubMed ID: 23401467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced sputum and occupational diseases other than asthma.
    Fireman E
    Curr Opin Allergy Clin Immunol; 2009 Apr; 9(2):93-6. PubMed ID: 19326503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers.
    Smountas AA; Lands LC; Mohammed SR; Grey V
    Clin Biochem; 2004 Nov; 37(11):1031-6. PubMed ID: 15498533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction.
    Bartoli ML; Di Franco A; Vagaggini B; Bacci E; Cianchetti S; Dente FL; Tonelli M; Paggiaro PL
    Respiration; 2009; 77(3):265-72. PubMed ID: 19075557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical applications of induced sputum.
    Brightling CE
    Chest; 2006 May; 129(5):1344-8. PubMed ID: 16685028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity of induced sputum and bronchoalveolar lavage in childhood asthma.
    Kim CK; Koh YY; Callaway Z
    J Asthma; 2009 Mar; 46(2):105-12. PubMed ID: 19253112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
    Tsoumakidou M; Papadopouli E; Tzanakis N; Siafakas NM
    Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
    Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
    Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeatability of inflammatory parameters in induced sputum of COPD patients.
    Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
    COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.
    Terracciano R; Preianò M; Palladino GP; Carpagnano GE; Barbaro MP; Pelaia G; Savino R; Maselli R
    Proteomics; 2011 Aug; 11(16):3402-14. PubMed ID: 21751363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers.
    Khurana S; Ravi A; Sutula J; Milone R; Williamson R; Plumb J; Vestbo J; Singh D
    Respir Med; 2014 Dec; 108(12):1761-70. PubMed ID: 25459449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods of examining induced sputum: do differences matter?
    Kips JC; Peleman RA; Pauwels RA
    Eur Respir J; 1998 Mar; 11(3):529-33. PubMed ID: 9596097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.